American Journal of Respiratory and Critical Care Medicine

Journal

Publication Venue For

  • Video Telehealth Pulmonary Rehabilitation Intervention In COPD Reduces 30-day Readmissions. 2019
  • Chronic Obstructive Pulmonary Disease in America's Black Population. 2019
  • Arterial Vascular Pruning, Right Ventricular Size and Clinical Outcomes in COPD. 2019
  • Imaging advances in chronic obstructive pulmonary disease insights from the genetic epidemiology of chronic obstructive pulmonary disease (COPDGene) study.  199:286-301. 2019
  • Life-course smoking trajectories and risk for emphysema in middle age: The CARDIA Lung study.  199:237-240. 2019
  • Reply to Eapen et al.: Dysfunctional immunity and microbial adhesion molecules in smoking-induced pneumonia.  199:251-252. 2019
  • ADAM9: A damaging player in chronic obstructive pulmonary disease.  198:1465-1466. 2018
  • Nosocomial pneumonia elicits an endothelial proteinopathy: Evidence for a source of neurotoxic amyloids in critically ill patients.  198:1575-1578. 2018
  • Longitudinal phenotypes and mortality in preserved ratio impaired spirometry in the COPDGene study.  198:1397-1405. 2018
  • Macrophage Rac2 is required to reduce the severity of cigarette smoke-induced pneumonia.  198:1288-1301. 2018
  • A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE)..  198:1151-1164. 2018
  • Ataluren, a new therapeutic for alpha-1 antitrypsin-deficient individuals with nonsense mutations.  198:1099-1102. 2018
  • Protein tyrosine phosphatase-N13 promotes myofibroblast resistance to apoptosis in idiopathic pulmonary fibrosis.  198:914-927. 2018
  • Maternal smoking induces acquired CFTR dysfunction in neonatal rats.  198:672-674. 2018
  • Reversing mechanoinductive DSP expression by CRISPR/dCas9–mediated epigenome editing.  198:599-609. 2018
  • Changes in lung clearance index in preschool-aged patients with cystic fibrosis treated with ivacaftor (GOAL): A clinical trial.  198:526-528. 2018
  • Defining impaired respiratory health a paradigm shift for pulmonary medicine.  198:440-446. 2018
  • Early chronic obstructive pulmonary disease or early detection of mild disease?.  198:411-412. 2018
  • Future research directions in pneumonia.  198:256-263. 2018
  • Things we “kNOw” and do not “kNOw” about pulmonary hypertension.  198:151-152. 2018
  • Exacerbations of chronic obstructive pulmonary disease and cardiac events a post hoc cohort analysis from the SUMMIT randomized clinical trial.  198:51-57. 2018
  • Control of breathing in preterm infants: Neonatal ICU and beyond.  197:1518-1520. 2018
  • Generic respiratory symptoms and branded lung diseases: Same Difference?.  197:1521-1523. 2018
  • Respiratory symptoms in young adults and future lung disease the cardia lung study.  197:1616-1624. 2018
  • Ivacaftor-treated patients with cystic fibrosis derive long-term benefit despite no short-term clinical improvement.  197:1483-1486. 2018
  • Reply to shah et al..  197:1363-1364. 2018
  • Does extracorporeal membrane oxygenation improve survival in pediatric acute respiratory failure?.  197:1177-1186. 2018
  • Novel method for noninvasive sampling of the distal airspace in acute respiratory distress syndrome.  197:1027-1035. 2018
  • MicroRNA-145 antagonism reverses TGF-b inhibition of F508del CFTR correction in airway Epithelia.  197:632-643. 2018
  • Quantitative evidence for revising the definition of primary graft dysfunction after lung transplant.  197:235-243. 2018
  • Cardiac morphometry on computed tomography and exacerbation reduction with β-blocker therapy in chronic obstructive pulmonary disease.  196:1484-1488. 2017
  • Signs of gas trapping in normal lung density regions in smokers.  196:1404-1410. 2017
  • Home monitoring of patients with cystic fibrosis to identify and treat acute pulmonary exacerbations eICE study results.  196:1144-1151. 2017
  • Recovery from critical illness: Physical rehabilitation in the intensive care unit, timing of persistent critical illness, and caregiver outcomes.  196:1068-1070. 2017
  • Vascular endothelial mitochondrial function predicts death or pulmonary outcomes in preterm infants.  196:1040-1049. 2017
  • Computed tomography measure of lung at risk and lung function decline in chronic obstructive pulmonary disease.  196:569-576. 2017
  • Severe pneumococcal pneumonia causes acute cardiac toxicity and subsequent cardiac remodeling.  196:609-620. 2017
  • FEV1 decline in patients with chronic obstructive pulmonary disease: Reply.  195:1677. 2017
  • Pulmonary hypertension and precision medicine through the "omics" looking glass.  195:1558-1560. 2017
  • Association between cardiorespiratory fitness and lung health from young adulthood to middle ages.  195:1236-1243. 2017
  • Effect of fluticasone furoate and vilanterol on exacerbations of chronic obstructive pulmonary disease in patients with moderate airflow obstruction.  195:881-888. 2017
  • Sequelae of donor-derived mollicutes transmission in lung recipients.  195:687-689. 2017
  • Reply: FEV1 Decline in Patients with Chronic Obstructive Pulmonary Disease..  195:1677. 2017
  • Acute exacerbations and lung function loss in smokers with and without chronic obstructive pulmonary disease.  195:324-330. 2017
  • What is in a pattern? that which we call idiopathic pulmonary fibrosis by any other pattern would behave alike!.  195:10-12. 2017
  • Genetics and genomics of longitudinal lung function patterns in individuals with asthma.  194:1465-1474. 2016
  • All about Asthma: Association with Obstructive Sleep Apnea, Management, and Overlap with Chronic Obstructive Pulmonary Disease.  194:1423-1425. 2016
  • National institute of environmental health sciences: 50 years of advancing science and improving lung health.  194:1190-1195. 2016
  • Discovery of clinically approved agents that promote suppression of cystic fibrosis transmembrane conductance regulator nonsense mutations.  194:1092-1103. 2016
  • Hidden in plain sight: Lung impairment in ischemic heart disease.  194:528-530. 2016
  • Reply.  194:522. 2016
  • Reply: It Is Too Early to Say No Place for High-Frequency Oscillatory Ventilation in Children with Respiratory Failure..  194:522. 2016
  • Association between functional small airway disease and FEV1 decline in chronic obstructive pulmonary disease.  194:178-184. 2016
  • Compartmentalization is key in limiting nitric oxide scavenging by cell-free hemoglobin.  193:1072-1074. 2016
  • Reply.  193:1068-1069. 2016
  • Reply: Do We Really Know How to Use High-Frequency Oscillatory Ventilation in Critically Ill Children?.  193:1068-1069. 2016
  • Oxidative modifications of protein tyrosyl residues are increased in plasma of human subjects with interstitial lung disease.  193:861-866. 2016
  • Early high-frequency oscillatory ventilation in pediatric acute respiratory failure: A propensity score analysis.  193:495-503. 2016
  • Glycolytic reprogramming in myofibroblast differentiation and lung fibrosis.  192:1462-1474. 2015
  • Recovery of acquired cystic fibrosis transmembrane conductance regulator dysfunction after smoking cessation.  192:1521-1524. 2015
  • Endothelin-1 pathway polymorphisms and outcomes in pulmonary arterial hypertension.  192:1345-1354. 2015
  • A fragment in time: Elastin peptides and progression of emphysema.  192:1141-1143. 2015
  • Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation.  191:455-463. 2015
  • Increased resource use in lung transplant admissions in the lung allocation score era.  191:302-308. 2015
  • A randomized, placebo-controlled trial of roflumilast effect on proline-glycine-proline and neutrophilic inflammation in chronic obstructive pulmonary disease.  192:934-942. 2015
  • Blue Journal Conference: Aging and susceptibility to lung disease.  191:261-269. 2015
  • Cardiotoxicity during invasive pneumococcal disease.  191:739-745. 2015
  • Noninvasive computed tomography-based risk stratification of lung adenocarcinomas in the national lung screening trial.  192:737-744. 2015
  • Extracorporeal membrane oxygenation for acute respiratory failure in adults: The need for pulmonary INTERMACS.  190:1321-1322. 2014
  • Is pulmonary hypertension a metabolic disease?.  190:973-975. 2014
  • Wnt/b-Catenin and transforming growth factor-B signaling in pulmonary fibrosis: A case for antagonistic pleiotropy?.  190:129-131. 2014
  • Wnt/β-catenin and transforming growth factor-β signaling in pulmonary fibrosis. A case for antagonistic pleiotropy?.  190:129-131. 2014
  • An aberrant leukotriene A4 hydrolase-proline-glycine-proline pathway in the pathogenesis of chronic obstructive pulmonary disease.  190:51-61. 2014
  • Plasma complement levels are associated with primary graft dysfunction and mortality after lung transplantation.  189:1564-1567. 2014
  • Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy.  189:1503-1508. 2014
  • C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis.  189:966-974. 2014
  • Tertiary lymphoid structures target the antitumor immune response to lung cancer.  189:767-769. 2014
  • Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction.  189:567-575. 2014
  • Future directions in idiopathic pulmonary fibrosis research an NHLBI workshop report.  189:214-222. 2014
  • A functional anatomic defect of the cystic fibrosis airway.  190:421-432. 2014
  • A novel tumor necrosis factor-mediated mechanism of direct epithelial sodium channel activation.  190:522-532. 2014
  • Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis.  190:175-184. 2014
  • Genome-wide association identifies regulatory loci associated with distinct local histogram emphysema patterns.  190:399-409. 2014
  • Integrative "omic" analysis of experimental bacteremia identifies a metabolic signature that distinguishes human sepsis from systemic inflammatory response syndromes.  190:445-455. 2014
  • Thromboendarterectomy for chronic thromboembolic pulmonary hypertension in hereditary hemorrhagic telangiectasia.  189:112-114. 2014
  • Loss of salmeterol bronchoprotection against exercise in relation to ADRB2 Arg16Gly polymorphism and exhaled nitric oxide.  188:1407-1412. 2013
  • Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function.  188:1321-1330. 2013
  • Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function..  188:1321-1330. 2013
  • AECOPD: Acute exacerbations of chronic obstructive cardiopulmonary disease?.  188:1046-1048. 2013
  • S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis.  188:1137-1146. 2013
  • High-frequency oscillatory ventilation, microRNAs in pulmonary hypertension, and gastric residual volumes..  188:508-509. 2013
  • Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications.  188:231-239. 2013
  • Cyclooxygenase-2 inhibits T helper cell type 9 differentiation during allergic lung inflammation via down-regulation of IL-17RB.  187:812-822. 2013
  • Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses.  187:768-775. 2013
  • Clinical risk factors for primary graft dysfunction after lung transplantation.  187:527-534. 2013
  • Lactate, a novel trigger of transforming growth factor- βactivation in idiopathic pulmonary fibrosis.  186:701-703. 2012
  • A young hispanic with c.1646G>A mutation exhibits severe cystic fibrosis lung disease: Is ivacaftor an option for therapy?.  186:694-696. 2012
  • Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction.  186:622-632. 2012
  • Altered DNA methylation profile in idiopathic pulmonary fibrosis.  186:525-535. 2012
  • Variation in PTX3 is associated with primary graft dysfunction after lung transplantation.  186:546-552. 2012
  • Retinoic acid-related orphan receptor-α is induced in the setting of DNA damage and promotes pulmonary emphysema.  186:412-419. 2012
  • Modern age pathology of pulmonary arterial hypertension.  186:261-272. 2012
  • A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis.  186:88-95. 2012
  • Update in diffuse parenchymal lung disease 2011.  186:24-29. 2012
  • Biological insights from clinical trials and networks.  185:475-476. 2012
  • Computed axial tomography scans, calories, and computers.  185:584-585. 2012
  • Lung endothelial Ca 2+ and permeability response to platelet-activating factor is mediated by acid sphingomyelinase and transient receptor potential classical 6.  185:160-170. 2012
  • Obesity and primary graft dysfunction after lung transplantation: The lung transplant outcomes group obesity study.  184:1055-1061. 2011
  • A Trojan horse strategy to deliver amikacin to mycobacterial granulomas [2].  184:860-861. 2011
  • The missing link between smoking and COPD autoreactivity?.  184:747-749. 2011
  • Cyclooxygenase-2 regulates Th17 cell differentiation during allergic lung inflammation.  184:37-49. 2011
  • Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants.  183:1715-1722. 2011
  • Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort.  183:885-890. 2011
  • Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation.  183:379-387. 2011
  • Recommended Reading from the University of Alabama Fellows: J. Allen Cooper, Program Director..  183:411-412. 2011
  • Targeted delivery of amikacin into granuloma.  182:1546-1553. 2010
  • Urokinase-type plasminogen activator inhibits efferocytosis of neutrophils.  182:1516-1523. 2010
  • Macrophage migration inhibitory factor promotes tumor growth in the context of lung injury and repair.  182:1030-1037. 2010
  • Cystic fibrosis pulmonary guidelines: Pulmonary complications: Hemoptysis and pneumothorax.  182:298-306. 2010
  • Is there a doctor in the house? The downside of 24/7 attending coverage in academic intensive care units.  181:1280-1281. 2010
  • Challenges in translating preclinical studies to effective drug therapies in idiopathic pulmonary fibrosis.  181:532-533. 2010
  • Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results.  181:604-610. 2010
  • Latent herpesvirus infection augments experimental pulmonary fibrosis.  181:465-477. 2010
  • Safety and efficacy of an inhaled epidermal growth factor receptor inhibitor (BIBW 2948 BS) in chronic obstructive pulmonary disease.  181:438-445. 2010
  • Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis.  181:254-263. 2010
  • What is autoimmunity and why is it likely to be important in chronic lung disease?.  181:4-5. 2010
  • Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction.  180:1010-1015. 2009
  • Deletion of Pten expands lung epithelial progenitor pools and confers resistance to airway injury.  180:701-712. 2009
  • Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease.  180:499-505. 2009
  • Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension.  180:468-474. 2009
  • Are telomere lengths of leukocytes from patients with pulmonary fibrosis really genetically determined?.  179:852. 2009
  • Bcl-2 suppresses sarcoplasmic/endoplasmic reticulum Ca21-ATPase expression in cystic fibrosis airways role in oxidant-mediated cell death.  179:816-826. 2009
  • Biologic lung volume reduction in advanced upper lobe emphysema phase 2 results.  179:791-798. 2009
  • Antiinflammatory effects of hydrogen peroxide in neutrophil activation and acute lung injury.  179:694-704. 2009
  • Update in diffuse parenchymal lung disease 2008.  179:439-444. 2009
  • Insulin-Like growth factor-i receptor blockade improves outcome in mouse model of lung injury.  179:212-219. 2009
  • Gamma Delta T Cells Attenuate Pulmonary Fibrosis through the Production of IP-10.  179. 2009
  • Regulation of Thy-1 Expression by Histone Modifications in Lung Fibroblast..  179. 2009
  • STAT4-Dependent, T-Bet Independent Lung Immune Responses to Pneumocystis.  179. 2009
  • The Absence of Hck, Fgr and Lyn Tyrosine Kinases Augments Lung Innate Immune Responses to Pneumocystis.  179. 2009
  • Potential role of high-mobility group box 1 in cystic fibrosis airway disease.  178:822-831. 2008
  • CD28 down-regulation on CD4 T cells is a marker for graft dysfunction in lung transplant recipients.  178:765-773. 2008
  • Idiopathic pulmonary fibrosis: A disorder of lung regeneration?.  178:663-665. 2008
  • Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury.  178:168-179. 2008
  • Screening contacts of tuberculosis: Overcoming obstacles with an old tool.  177:939-940. 2008
  • Autoantibodies in patients with chronic obstructive pulmonary disease.  177:156-163. 2008
  • BUILD-1: A randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis.  177:75-81. 2008
  • Ozone, a malady for all ages.  176:107-108. 2007
  • Lung cells from neonates show a mesenchymal stem cell phenotype.  175:1158-1164. 2007
  • Idiopathic interstitial pneumonia: Do community and academic physicians agree on diagnosis?.  175:1054-1060. 2007
  • Importance of phosphoinositide 3-kinase γ in the host defense against pneumococcal infection.  175:958-966. 2007
  • One more prediction rule: Has anything new been added? [1].  175:743. 2007
  • Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction.  175:69-74. 2007
  • Children's secondhand smoke exposure in African-American families 2007
  • Measurement of secondhand smoke exposure in children using a point of care urine dipstick assay for cotinine 2007
  • Modulatory role for retinoid-related orphan receptor α in allergen-induced lung inflammation.  174:1299-1309. 2006
  • Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: An NHLBI workshop report.  174:373-378. 2006
  • Leflunomide prevents alveolar fluid clearance inhibition by respiratory syncytial virus.  173:673-682. 2006
  • Reactive species mediate inhibition of alveolar type II sodium transport during mycoplasma infection.  173:334-344. 2006
  • Classification of interstitial pneumonias: What do gene expression profiles tell us?.  173:141-142. 2006
  • Reevaluating neonatal resuscitation with 100% oxygen.  172:1360-1361. 2005
  • The mysterious pulmonary brush cell: A cell in search of a function.  172:136-139. 2005
  • Oleic acid damages ion transport promotes alveolar edema: The dark side of healthy living.  171:424-425. 2005
  • Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection.  170:1331-1339. 2004
  • Loss of bone density with inhaled triamcinoline in lung health study II.  170:1302-1309. 2004
  • Immunostimulatory oligonucleotides attenuate airways remodeling in allergic monkeys.  170:1153-1157. 2004
  • Asthma self-management, self-efficacy, and resilience in adolescents attending asthma camp 2004
  • Parent and child agreement on questionnaires for asthma case detection 2004
  • Integrin α4β1 regulates migration across basement membranes by lung fibroblasts: A role for phosphatase and tensin homologue deleted on chromosome 10.  168:436-442. 2003
  • A Genome-Wide Scan of Pulmonary Function Measures in the National Heart, Lung, and Blood Institute Family Heart Study.  167:1528-1533. 2003
  • Fibroblastic foci in usual interstitial pneumonia: Idiopathic versus collagen vascular disease.  167:1410-1415. 2003
  • Statin use is associated with improved function and survival of lung allografts.  167:1271-1278. 2003
  • Nontuberculous mycobacteria: I: Multicenter prevalence study in cystic fibrosis.  167:828-834. 2003
  • Secondhand smoke exposure and school-age children 2003
  • A decision tree for tuberculosis contact investigation.  166:1122-1127. 2002
  • Fibrinolysis in the pleural space. Breaking the bonds that bind.  166:909-910. 2002
  • ATS statement: Guidelines for the six-minute walk test.  166:111-117. 2002
  • Oligoclonal CD4+T cell expansions in lung transplant recipients with obliterative bronchiolitis.  165:1439-1444. 2002
  • Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: A double-blind, randomized, placebo-controlled trial.  165:800-804. 2002
  • Genetic loci influencing lung function: A genomewide scan in the Framingham Study.  165:795-799. 2002
  • Asthma education in elementary school children and teachers 2002
  • ETS avoidance behaviors 2002
  • Heritability of longitudinal change in lung function: The Framingham study.  164:1655-1659. 2001
  • Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis.  164:193-196. 2001
  • Attenuation of interleukin 8-induced nasal inflammation by an inhibitor peptide.  163:1198-1205. 2001
  • Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis.  163:1683-1692. 2001
  • Increased levels of nitrate and surfactant protein A nitration in the pulmonary edema fluid of patients with acute lung injury.  163:166-172. 2001
  • Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome.  163:503-510. 2001
  • Trends in asthma prevalence and morbidity in Head Start graduates 2001
  • Use of a long-acting inhaled β2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease.  163:1087-1092. 2001
  • Talc induces apoptosis in human malignant mesothelioma cells in vitro..  161:595-600. 2000
  • Asthma prevalence and morbidity in Head Start Graduates 2000
  • Cyclophosphamide prevents systemic keratinocyte growth factor-induced up-regulation of surfactant protein A after allogeneic transplant in mice.  162:1884-1890. 2000
  • DETANONOate, a nitric oxide donor, decreases amiloride-sensitive alveolar fluid clearance in rabbits.  161:1154-1160. 2000
  • Heterogeneous geographic distribution of inner city pediatric asthma admissions in Birmingham 2000
  • Management of malignant pleural effusions.  162:1987-2001. 2000
  • Protein nitration, metabolites of reactive nitrogen species, and inflammation in lung allografts.  161:2035-2042. 2000
  • Results of a school-based multi-stage screening procedure for asthma 2000
  • School environments and children with asthma 2000
  • Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease: The lung health study.  161:381-390. 2000
  • Talc induces apoptosis in human malignant mesothelioma cells in vitro.  161:595-600. 2000
  • Helper T cell type 1 and 2 cytokines regulate C-C chemokine expression in mouse pleural mesothelial cells..  159:1653-1659. 1999
  • Helper T cell type 1 and 2 cytokines regulate C-C chemokine expression in mouse pleural mesothelial cells.  159:1653-1659. 1999
  • Identification of questions that best predict new diagnosis of asthma in children 1999
  • Reporting of symptoms in childhood asthma: Parent and child comparisons 1999
  • Segregation analysis of pulmonary function among families in the framingham study.  157:1445-1451. 1998
  • Advances in prevention and education in lung disease.  157. 1998
  • Talc-induced expression of C-C and C-X-C chemokines and intercellular adhesion molecule-1 in mesothelial cells.  158:971-978. 1998
  • Upregulation of xanthine oxidase by lipopolysaccharide, interleukin-1, and hypoxia: Role in acute lung injury.  158:299-305. 1998
  • The epithelium as a target of glucocorticoid action in the treatment of asthma.  154. 1996
  • The epithelium as a target of glucocorticoid action in the treatment of asthma..  154:S16-S19. 1996
  • Acute safety and effects on mucociliary clearance of aerosolized uridine 5'-triphosphate ± amiloride in normal human adults.  154:217-223. 1996
  • Aerosolized cyclosporine in lung recipients with refractory chronic rejection.  153:1451-1455. 1996
  • Lung injury after hepatoenteric ischemia-reperfusion: Role of xanthine oxidase.  154:1364-1369. 1996
  • Transmission of Mycobacterium tuberculosis to recipients of single lung transplants from the same donor.  153:1166-1168. 1996
  • Evidence for in vivo peroxynitrite production in human acute lung injury..  151:1250-1254. 1995
  • Clinical risk factors for pulmonary barotrauma: A multivariate analysis.  152:1235-1240. 1995
  • Delivery and distribution of aerosolized cyclosporine in lung allograft recipients.  151:516-521. 1995
  • Hyperoxic lung injury reduces exogenous surfactant clearance in vivo.  151:1843-1847. 1995
  • Laboratory contamination of Mycobacterium tuberculosis cultures.  152:1702-1704. 1995
  • Development of pulmonary infection in mice inoculated with Blastomyces dermatitidis conidia..  149:500-509. 1994
  • Measures for use in asthma clinical research. Overview of the NIH workshop..  149:S1-S8. 1994
  • A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.  150:146-152. 1994
  • Development of pulmonary infection in mice inoculated with Blastomyces dermatitidis conidia.  149:500-509. 1994
  • Load detection in subjects with sleep-induced upper airway obstruction.  149:727-730. 1994
  • International Standard Serial Number (issn)

  • 1073-449X
  • Electronic International Standard Serial Number (eissn)

  • 1073-449X
  • 1535-4970